These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 35285220)
21. Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events. Xu KY; Presnall N; Mintz CM; Borodovsky JT; Bhat NR; Bierut LJ; Grucza RA JAMA Netw Open; 2021 Feb; 4(2):e210061. PubMed ID: 33625511 [TBL] [Abstract][Full Text] [Related]
22. Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks. Camenga DR; Colon-Rivera HA; Muvvala SB J Stud Alcohol Drugs; 2019 Jul; 80(4):393-402. PubMed ID: 31495374 [TBL] [Abstract][Full Text] [Related]
23. A Comparison of Medication-Assisted Treatment Options for Opioid Addiction: A Review of the Literature. Spayde-Baker A; Patek J J Addict Nurs; 2023 Oct-Dec 01; 34(4):E189-E194. PubMed ID: 34224485 [TBL] [Abstract][Full Text] [Related]
24. Impact of treatment duration on mortality among Veterans with opioid use disorder in the United States Veterans Health Administration. Ching JH; Owens DK; Trafton JA; Goldhaber-Fiebert JD; Salomon JA Addiction; 2021 Dec; 116(12):3494-3503. PubMed ID: 33999485 [TBL] [Abstract][Full Text] [Related]
25. The case for a medication first approach to the treatment of opioid use disorder. Winograd RP; Presnall N; Stringfellow E; Wood C; Horn P; Duello A; Green L; Rudder T Am J Drug Alcohol Abuse; 2019; 45(4):333-340. PubMed ID: 31084515 [No Abstract] [Full Text] [Related]
26. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities. Gordon AJ; Drexler K; Hawkins EJ; Burden J; Codell NK; Mhatre-Owens A; Dungan MT; Hagedorn H Subst Abus; 2020; 41(3):275-282. PubMed ID: 32697170 [TBL] [Abstract][Full Text] [Related]
27. Association of Medication-Assisted Therapy with New Onset of Cardiac Arrhythmia in Patients Diagnosed with Opioid Use Disorders. Raji MA; Priyadarshni S; Yu X; Digbeu B; Kuo YF Am J Med; 2022 Jul; 135(7):864-870.e3. PubMed ID: 35139325 [TBL] [Abstract][Full Text] [Related]
28. Medication Treatment of Opioid Use Disorder. Bell J; Strang J Biol Psychiatry; 2020 Jan; 87(1):82-88. PubMed ID: 31420089 [TBL] [Abstract][Full Text] [Related]
29. Medication-assisted treatment for opioid use disorder within a 12-step based treatment center: Feasibility and initial results. Klein AA; Seppala MD J Subst Abuse Treat; 2019 Sep; 104():51-63. PubMed ID: 31370985 [TBL] [Abstract][Full Text] [Related]
30. Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems. Boudreau DM; Lapham G; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Campbell CI; Rossom RC; Binswanger IA; Yarborough BJ; Arnsten JH; Cunningham CO; Glass JE; Murphy MT; Zare M; Hechter RC; Ahmedani B; Braciszewski JM; Horigian VE; Szapocznik J; Samet JH; Saxon AJ; Schwartz RP; Bradley KA J Subst Abuse Treat; 2020 Mar; 112S():41-48. PubMed ID: 32220410 [TBL] [Abstract][Full Text] [Related]
31. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial. Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653 [TBL] [Abstract][Full Text] [Related]
32. Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting. Carswell N; Angermaier G; Castaneda C; Delgado F Hosp Pract (1995); 2022 Oct; 50(4):251-258. PubMed ID: 35837678 [TBL] [Abstract][Full Text] [Related]
33. Implementation of office-based buprenorphine treatment for opioid use disorder. Carroll E J Am Assoc Nurse Pract; 2021 Mar; 34(1):196-204. PubMed ID: 33767120 [TBL] [Abstract][Full Text] [Related]
34. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail. Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100 [TBL] [Abstract][Full Text] [Related]
35. County-level access to opioid use disorder medications in medicare Part D (2010-2015). Abraham AJ; Adams GB; Bradford AC; Bradford WD Health Serv Res; 2019 Apr; 54(2):390-398. PubMed ID: 30665272 [TBL] [Abstract][Full Text] [Related]
36. Help Is on the Way: Medicare Coverage of Opioid Treatment Programs. Felix C; Sharfstein JM; Olsen Y J Am Geriatr Soc; 2020 Mar; 68(3):637-640. PubMed ID: 31825528 [TBL] [Abstract][Full Text] [Related]
37. Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients. Herscher M; Fine M; Navalurkar R; Hirt L; Wang L Med Clin North Am; 2020 Jul; 104(4):695-708. PubMed ID: 32505261 [TBL] [Abstract][Full Text] [Related]
38. Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review. Korthuis PT; McCarty D; Weimer M; Bougatsos C; Blazina I; Zakher B; Grusing S; Devine B; Chou R Ann Intern Med; 2017 Feb; 166(4):268-278. PubMed ID: 27919103 [TBL] [Abstract][Full Text] [Related]
39. Implementation of a Medication for Addiction Treatment (MAT) and Linkage Program by Leveraging Community Partnerships and Medical Toxicology Expertise. Beauchamp GA; Laubach LT; Esposito SB; Yazdanyar A; Roth P; Lauber P; Allen J; Boateng N; Shaak S; Burmeister DB J Med Toxicol; 2021 Apr; 17(2):176-184. PubMed ID: 33146875 [TBL] [Abstract][Full Text] [Related]
40. Update on pharmacotherapy for treatment of opioid use disorder. Ayanga D; Shorter D; Kosten TR Expert Opin Pharmacother; 2016 Dec; 17(17):2307-2318. PubMed ID: 27734745 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]